Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Bioventus Inc

Current price
5.82 USD -0.04 USD (-0.68%)
Last closed 5.94 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 371 476 640 USD
Yield for 12 month +87.14 %
21.11.2021 - 28.11.2021

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina. Address: 4721 Emperor Boulevard, Durham, NC, United States, 27703

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

8.5 USD

P/E ratio

Dividend Yield

Current Year

+512 345 000 USD

Last Year

+512 117 000 USD

Current Quarter

+129 457 000 USD

Last Quarter

+135 423 000 USD

Current Year

+319 351 000 USD

Last Year

+331 080 000 USD

Current Quarter

+86 625 000 USD

Last Quarter

+84 199 000 USD

Key Figures BVS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 42 622 000 USD
Operating Margin TTM 4.34 %
PE Ratio
Return On Assets TTM 1.52 %
PEG Ratio 2.1421
Return On Equity TTM -11.87 %
Wall Street Target Price 8.5 USD
Revenue TTM 522 743 008 USD
Book Value 2.69 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 8.7 %
Dividend Yield
Gross Profit TTM 302 706 000 USD
Earnings per share -0.33 USD
Diluted Eps TTM -0.33 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -4.14 %

Dividend Analytics BVS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BVS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation BVS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 38.0228
Enterprise Value Revenue 1.2638
Price Sales TTM 0.5653
Enterprise Value EBITDA -28.0678
Price Book MRQ 2.0841

Financials BVS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BVS

For 52 weeks

2.7 USD 7.04 USD
50 Day MA 5.51 USD
Shares Short Prior Month 695 949
200 Day MA 4.58 USD
Short Ratio 1.95
Shares Short 591 325
Short Percent 1.6 %

Dynamics of changes in the value of assets




446.34 USD Microsoft Corporation -3.37 (-0.75%)
Detailed analytics

ETF funds



203.95 CHF UBS SLI A-dis -0.06 (-0.02%)
Detailed analytics



2339.94 USD Gold +11.09 (+0.48%)
Detailed analytics